Coeptis Therapeutics Holdings Future Growth
Future criteria checks 0/6
Coeptis Therapeutics Holdings's earnings are forecast to decline at 6.8% per annum. EPS is expected to grow by 28.1% per annum.
Key information
-6.8%
Earnings growth rate
28.1%
EPS growth rate
| Biotechs earnings growth | 28.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 17 Jun 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | N/A | -16 | -7 | -7 | N/A |
| 3/31/2024 | N/A | -16 | -7 | -7 | N/A |
| 12/31/2023 | N/A | -21 | -7 | -7 | N/A |
| 9/30/2023 | N/A | -20 | -6 | -6 | N/A |
| 6/30/2023 | N/A | -20 | -5 | -5 | N/A |
| 3/31/2023 | N/A | -26 | -5 | -5 | N/A |
| 12/31/2022 | N/A | -38 | -4 | -4 | N/A |
| 9/30/2022 | N/A | -37 | 0 | -3 | N/A |
| 6/30/2022 | N/A | -38 | -7 | -6 | N/A |
| 3/31/2022 | N/A | -31 | -7 | -5 | N/A |
| 12/31/2021 | 0 | -13 | -6 | -4 | N/A |
| 9/30/2021 | 0 | -15 | -10 | -5 | N/A |
| 6/30/2021 | 0 | -11 | -3 | -2 | N/A |
| 3/31/2021 | 0 | -9 | -2 | -2 | N/A |
| 12/31/2020 | 0 | -9 | -3 | -3 | N/A |
| 12/31/2019 | 0 | -2 | -2 | -4 | N/A |
| 12/31/2018 | 0 | -2 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COEP is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: COEP is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: COEP is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if COEP's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if COEP's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if COEP's Return on Equity is forecast to be high in 3 years time